Targeting ROR1 in combination with osimertinib in EGFR mutant lung cancer cells.
Exp Cell Res
; 409(2): 112940, 2021 12 15.
Article
in En
| MEDLINE
| ID: mdl-34808132
Full text:
1
Database:
MEDLINE
Main subject:
Acrylamides
/
Carcinoma, Non-Small-Cell Lung
/
Drug Resistance, Neoplasm
/
RNA, Small Interfering
/
Receptor Tyrosine Kinase-like Orphan Receptors
/
Aniline Compounds
/
Mutation
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Year:
2021
Type:
Article